Variables | Cases (n = 199) | Controls (n = 200) | p value |
---|---|---|---|
Sex N | 0.966b | ||
Male | 115 | 116 | |
Female | 84 | 84 | |
Age, years (mean ± SD) | 41.15 ± 12.934 | 41.20 ± 8.662 | 0.961a |
Clinical stages | |||
Stage II | 47 | ||
Stage III | 94 | ||
Stage IV | 58 | ||
Hip lesions | |||
unilateral | 59 | ||
bilateral | 140 | ||
TC (mmol/L) | 4.50 ± 0.923 | 4.54 ± 0.814 | 0.703 |
TG (mmol/L) | 1.84 ± 1.455 | 1.76 ± 1.076 | 0.569 |
HDL-C (mmol/L) | 1.07 ± 0.269 | 1.15 ± 0.214 | 0.000a |
LDL-C (mmol/L) | 2.64 ± 0.765 | 2.56 ± 0.728 | 0.285 |
TC/HDL-C | 4.41 ± 1.178 | 4.04 ± 0.856 | 0.000a |
TG/HDL-C | 1.94 ± 1.930 | 1.64 ± 1.149 | 0.059 |
LDL-C/HDL-C | 2.58 ± 0.821 | 2.30 ± 0.767 | 0.001a |